BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

936 related articles for article (PubMed ID: 18093259)

  • 1. Dry-eye syndrome after allogeneic stem-cell transplantation in children.
    Fahnehjelm KT; Törnquist AL; Winiarski J
    Acta Ophthalmol; 2008 May; 86(3):253-8. PubMed ID: 18093259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual outcome and cataract development after allogeneic stem-cell transplantation in children.
    Fahnehjelm KT; Törnquist AL; Olsson M; Winiarski J
    Acta Ophthalmol Scand; 2007 Nov; 85(7):724-33. PubMed ID: 17725615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease.
    Russo PA; Bouchard CS; Galasso JM
    Eye Contact Lens; 2007 May; 33(3):144-7. PubMed ID: 17502749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dry eye in graft-versus-host disease].
    Fei WL; Chen JQ; Du X; Liu YH; Sun MX; Lin JX; Weng JY; Luo TZ; Yin DM; Luo XY
    Zhonghua Yan Ke Za Zhi; 2003 Nov; 39(11):686-90. PubMed ID: 14766066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Ogawa Y; Okamoto S; Mori T; Yamada M; Mashima Y; Watanabe R; Kuwana M; Tsubota K; Ikeda Y; Oguchi Y
    Bone Marrow Transplant; 2003 Apr; 31(7):579-83. PubMed ID: 12692625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of lipid layer thickness of tear film in the diagnosis of dry-eye syndrome in children after the hematopoietic stem cell transplantation].
    Kurpińska M; Gorczyńska E; Owoc-Lempach J; Bernacka A; Misiuk-Hojło M; Chybicka A
    Klin Oczna; 2011; 113(4-6):136-40. PubMed ID: 21913442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Corneal complications after hematopoietic stem cell transplantation].
    Mittelviefhaus H; Auw-Hädrich C
    Ophthalmologe; 2003 Mar; 100(3):222-9. PubMed ID: 12640552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical cyclosporine-A in dry eye associated with chronic graft versus host disease.
    Kurt RA; Yalçindag N; Atilla H; Arat M
    Ann Ophthalmol (Skokie); 2009; 41(3-4):166-9. PubMed ID: 20214049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular graft-versus-host disease after allogeneic stem cell transplantation.
    Westeneng AC; Hettinga Y; Lokhorst H; Verdonck L; van Dorp S; Rothova A
    Cornea; 2010 Jul; 29(7):758-63. PubMed ID: 20489577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.
    Rao SN; Rao RD
    Cornea; 2006 Jul; 25(6):674-8. PubMed ID: 17077659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E; Asfuroğlu E
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of dry eye related to systemic diseases in childhood and longterm follow-up.
    Mac Cord Medina F; Silvestre de Castro R; Leite SC; Rocha EM; de Melo Rocha G
    Acta Ophthalmol Scand; 2007 Nov; 85(7):739-44. PubMed ID: 17559557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal grafting and aggressive medication for corneal defects in graft-versus-host disease following bone marrow transplantation.
    Tarnawska D; Wylegała E
    Eye (Lond); 2007 Dec; 21(12):1493-500. PubMed ID: 17057649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agenesis and microdontia of permanent teeth as late adverse effects after stem cell transplantation in young children.
    Hölttä P; Alaluusua S; Saarinen-Pihkala UM; Peltola J; Hovi L
    Cancer; 2005 Jan; 103(1):181-90. PubMed ID: 15540242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ophthalmic cyclosporine use in ocular GVHD.
    Lelli GJ; Musch DC; Gupta A; Farjo QA; Nairus TM; Mian SI
    Cornea; 2006 Jul; 25(6):635-8. PubMed ID: 17077652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of dry eye syndrome after allogeneic hematopoietic stem cell transplantation.
    Ivanir Y; Shimoni A; Ezra-Nimni O; Barequet IS
    Cornea; 2013 May; 32(5):e97-101. PubMed ID: 23187163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
    Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
    Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A 0,05% cyclosporine treatment of the advanced dry eye syndrome].
    Kujawa A; Rózycki R
    Klin Oczna; 2005; 107(4-6):280-6. PubMed ID: 16118939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.